Guidance for the Notification of Serious Breaches of GCP or the Trial Protocol, Version 6, 08 Jul 2020, MHRA
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
G. Organisation Responsibilities
Appendix I - Expectations for Specific Serious Breach Topics
Appendix II Examples of Serious Breaches Notified to MHRA (this is not an exhaustive list)
Source: Medicines & Healthcare products Regulatory Agency, the UK.
Clinical Research News
即将进行的临床试验
-
NCT05895201尚未招聘急性髓性白血病 | 骨髓增生异常综合征 | 慢性粒单核细胞白血病 | 成人急性淋巴细胞白血病 | 骨髓移植并发症
-
NCT05895344尚未招聘海绵窦脑膜瘤 | 质子治疗 | 光子放射治疗 | 认知和功能影响
Clinical Research Jobs
-
CRA (Level II) - Paris - Home-based
-
Clin Ops Delivery Associate I
-
Site Alliance Manager
-
eClinical Business Lead - Poland, Romania, Italy, Spain, Hungary, Lithuania
-
Senior Clinical Research Associate - Paris (FSP)
-
Clinical Trial Payments Coordinator (FSP) Warsaw
-
Senior Clinical Research Associate (FSP) - Warsaw
-
Project Manager - Early Phase Clinical Operations
-
Senior Regulatory Affairs Associate
-
Senior Associate - Clinical Outcomes Assessment
-
IRT Specialist
-
Site Intelligence Specialist (FSP)